Not finding it? Sign in to also search OpenAlex live.
-
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer2024 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Florien J G van Amstel, Cornelis Maarten de Mooij, Janine M. Simons, Cristina Mitea, P. J. van Diest, Patricia Joan Nelemans, +29 more
6citations -
Ultrasound localization microscopy for improved preselection and monitoring of breast cancer patients undergoing neoadjuvant chemotherapy2025 The Journal of the Acoustical Society of America conference-abstract Engineering Ultrasound and Hyperthermia Applications
Céline Porte, Matthias Kohlen, Thomas Lisson, Stefanie Dencks, Zuzanna Magnuska, Saskia Freifrau von Stillfried, +7 more
0citations -
The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer2026 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly MM Krol-Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, +3 more
1citations -
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy2022 BMC Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jonas Leichsenring, Valentina A. Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, +14 more
1citations -
Tumor-Infiltrating Lymphocytes and Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer: Insights From the Prospective PAPBI Cohort2025 International Journal of Radiation Oncology*Biology*Physics article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jetske L B Gunster, Emma Josephine Groen, Roberto Salgado, Corrie A.M. Marijnen, Astrid N. Scholten
3citations -
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial
Georgina Venetia Long, Nitya Nair, Daniel Marbach, Richard A. Scolyer, Sabine Wilson, Denise Cotting, +19 more
23citations -
The NADINA trial: A multicenter, randomised, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Minke W. Lucas, J. Lijnsvelt, Saskia M. Pulleman, Richard A. Scolyer, Alexander Maxwell Menzies, Alexander C. J. van Akkooi, +13 more
47citations -
Ribociclib–Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01)
Anne F. de Groot, Danielle Cohen, Joan Barbara Heijns, Caroline M.P.W. Mandigers, Agnes J. van de Wouw, Marissa Cloos‐van Balen, +13 more
4citations -
DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer—A Dutch Breast Cancer Research Group study (BOOG).2023 Journal of Clinical Oncology conference-abstract Medicine Dietary Effects on Health Open access
Nadia de Gruil, Gerrit‐Jan Liefers, Sanne B. Schagen, Elma Meershoek‐Klein Kranenbarg, Marielle E. Veen-Lievaart, Chris Hinnen, +12 more
1citations -
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma2024 New England Journal of Medicine article Medicine Cutaneous Melanoma Detection and Management Open access
Christian U Blank, Minke W Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +62 more
538citations -
Abstract P3-07-07: The use of ribociclib/letrozole combination as an alternative for neoadjuvant chemotherapy in selected patients with early luminal breast cancer
Anne Florine de Groot, Danielle B. Cohen, Joan Barbara Heijns, Caroline M.P.W. Mandigers, Diederick M. Keizer, Hein Putter, +7 more
2citations -
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial2020 PLoS ONE article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Paul Jank, Claire Gehlhaar, Bianca Lederer, Caterina Fontanella, Andreas Schneeweiss, Thomas Karn, +15 more
11citations